Newsroom
155 articles
FeaturedNew approval by the Medicines and Healthcare products Regulatory Agency (MHRA) of the medicine sotatercept (Winrevair) to treat pulmonary arterial hypertension (PAH). Sotatercept is used, in combination with…
FeaturedThe Medicines and Healthcare Products Regulatory Agency (MHRA) has approved tarlatamab (Imdylltra) as a treatment for adult patients with small cell lung cancer (SCLC) that has progressed to…
FeaturedThe U.S. Food and Drug Administration issued a draft guidance with the Office for Human Research Protections that will offer suggestions for incorporating tissue biopsies into clinical trials…
FeaturedThe Medicines and Healthcare products Regulatory Agency (MHRA) has approved the conditional marketing authorization of givinostat (Duvyzat), a medication used to treat Duchenne muscular dystrophy (DMD). Givinostat is…
FeaturedThe U.S. Food and Drug Administration authorized Ryoncil (remestemcel-L-rknd), an allogeneic (donor) bone marrow-derived mesenchymal stromal cell (MSC) therapy in order to steroid-refractory acute graft-versus-host disease (SR-aGVHD) in…
FeaturedThe U.S. Food and Drug Administration authorized the use of Crenessity (crinecerfont) in conjunction with glucocorticoids (steroids) to regulate the levels of androgen (a testosterone-like hormone) in adults…
FeaturedA recent study’s findings indicate that Alofisel, a medication used to treat complex anal fistulas in adults with Crohn’s disease, is ineffective. Based on the information at hand,…
FeaturedThe European Medicines Agency (EMA) has suggested that Welireg (belzutifan) be given a conditional marketing authorization in the EU for people with advanced renal cancer (RCC) who have…
FeaturedEuropean Medicines Agency (EMA) has recommended granting a marketing authorization in the European Union (EU) for Emcitate (tiratricol), an oral medication for individuals with peripheral thyrotoxicosis (unreasonably elevated…
FeaturedThe Holiday season is a busy time for all of us, our friends and our family. Consequently, we could overlook our health in the chaos to make sure…
FeaturedThe European Medicines Agency (EMA) has suggested expanding the use of Ofev (nintedanib) to treat progressive fibrosing interstitial lung disorders (ILDs) in children and adolescents starting at age…
FeaturedThe updated regulatory framework will expedite trial approvals and promote trial design innovation without affecting patient safety. New laws will be introduced in Parliament to address the need…
FeaturedThe Medicines and Healthcare products Regulatory Agency (MHRA) has approved the medicine flortaucipir (Tauvid), a radiopharmaceutical product given to adults with memory problems so that doctors can perform…
FeaturedFollowing a review of its initial opinion, EMA suggests revising the recommendations to reduce the possibility of interactions between the weight loss medication Mysimba (naltrexone/bupropion) and medications that…
FeaturedThe U.S. Food and Drug Administration approved Kebilidi (eladocagene exuparvovec-tneq), a gene therapy based on an adeno-associated virus vector that is recommended for the treatment of patients with…
Talk to our experts and get tailored solutions to help you stay compliant and move forward with confidence.
Submit RFI/RFP
Request Consultation
Submit RFI/RFP